FDA Orange Book · active-ingredient family
Fluocinolone acetonide
Fluocinolone acetonide: 9 brands, 68 generics; first approved Mar 04, 1982; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available: 68 ANDA applications approved.
Earliest patent expiry
Brands (NDA)
9
Generics (ANDA)
68
Listed patents
3
Next patent expiry
Aug 12, 2027
in 10 mo
Brand (NDA) products
Originator applications
- ALIMERA SCIENCES INCNDA 2103312018
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.18MG IMPLANT INTRAVITREAL Rx — - ALIMERA SCIENCES INCNDA 2019232014
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.19MG IMPLANT INTRAVITREAL Rx — - HILL DERMACNDA 01945220053 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Rx AT 0.01% OIL TOPICAL Rx AT 0.01% OIL/DROPS OTIC Rx AT - RETISERTRLDBAUSCH AND LOMBNDA 0217372005
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.59MG IMPLANT INTRAVITREAL Discontinued — - CAPEXRLDGALDERMA LABS LPNDA 0200011990
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SHAMPOO TOPICAL Discontinued — - EUROFARMANDA 012787—3 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Rx AT 0.01% CREAM TOPICAL Rx AT 0.025% CREAM TOPICAL Rx AT - EUROFARMANDA 013960—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% OINTMENT TOPICAL Rx AT - EUROFARMANDA 015296—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Rx AT - EUROFARMANDA 016161—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2% CREAM TOPICAL Discontinued —
Generic (ANDA) products (68)
Abbreviated applications
- FLUOCINOLONE ACETONIDENOVEL LABS INCANDA 2073472023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Rx AT - FLUOCINOLONE ACETONIDENOVEL LABS INCANDA 2073452023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Rx AT - FLUOCINOLONE ACETONIDEQUAGENANDA 2127622021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL/DROPS OTIC Rx AT - FLUOCINOLONE ACETONIDEQUAGENANDA 2127602021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Rx AT - FLUOCINOLONE ACETONIDEQUAGENANDA 2127612021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Rx AT - FLUOCINOLONE ACETONIDETP ANDA HOLDINGSANDA 2132642021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL/DROPS OTIC Rx AT - FLUOCINOLONE ACETONIDEENCUBE ETHICALSANDA 2099132019
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Rx AT - GLENMARK PHARMS LTDANDA 2118152018
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL/DROPS OTIC Discontinued — - FLUOCINOLONE ACETONIDECOSETTE PHARMS NCANDA 2107472018
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Rx AT - GLENMARK PHARMS LTDANDA 2105392018
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEGLENMARK PHARMS LTDANDA 2105562018
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Discontinued — - ANDA REPOSITORYANDA 2107362018
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL/DROPS OTIC Rx AT - FLUOCINOLONE ACETONIDECHARTWELL RXANDA 2095962017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Rx AT - FLUOCINOLONE ACETONIDEPADAGIS ISRAELANDA 2028492017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL/DROPS OTIC Rx AT - FLUOCINOLONE ACETONIDEACTAVIS LABS UT INCANDA 2083862016
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Discontinued — - FLUOCINOLONE ACETONIDECOSETTE PHARMS NCANDA 2074412016
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Discontinued — - FLUOCINOLONE ACETONIDESCIEGEN PHARMSANDA 2027052016
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL/DROPS OTIC Discontinued — - FLUOCINOLONE ACETONIDESUN PHARMA CANADAANDA 2023682016
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Rx AT - FLUOCINOLONE ACETONIDESUN PHARMA CANADAANDA 2093362016
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Rx AT - FLUOCINOLONE ACETONIDERISINGANDA 2033782016
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL/DROPS OTIC Rx AT - FLUOCINOLONE ACETONIDERISINGANDA 0909822016
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Rx AT - FLUOCINOLONE ACETONIDERISINGANDA 2033772016
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Rx AT - FLUOCINOLONE ACETONIDELUPINANDA 2064222015
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Rx AT - FLUOCINOLONE ACETONIDESCIEGEN PHARMSANDA 0915142015
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEPADAGIS ISRAELANDA 2028472013
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Rx AT - FLUOCINOLONE ACETONIDEPADAGIS ISRAELANDA 2028482013
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Rx AT - FLUOCINOLONE ACETONIDEAMNEALANDA 0913062011
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL/DROPS OTIC Discontinued — - FLUOCINOLONE ACETONIDEAMNEALANDA 2017592011
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEAMNEALANDA 2017642011
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% OIL TOPICAL Discontinued — - FLUOCINOLONE ACETONIDESUN PHARMA CANADAANDA 0400351994
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDESUN PHARMA CANADAANDA 0400421994
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDESUN PHARMA CANADAANDA 0400411994
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% OINTMENT TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEBAUSCH AND LOMBANDA 0400591993
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Discontinued — - FLUOCINOLONE ACETONIDECOSETTE PHARMS NCANDA 0895261988
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% CREAM TOPICAL Rx AT - FLUOCINOLONE ACETONIDECOSETTE PHARMS NCANDA 0895251988
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDECOSETTE PHARMS NCANDA 0895241988
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% OINTMENT TOPICAL Rx AT - FLUOCINOLONE ACETONIDESUN PHARMA CANADAANDA 0891241985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Rx AT - FLUOCINOLONE ACETONIDEUSL PHARMAANDA 0887561985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEUSL PHARMAANDA 0887571985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEUSL PHARMAANDA 0887421985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% OINTMENT TOPICAL Discontinued — - ALLERGAN HERBERTANDA 0871561984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Discontinued — - ALLERGAN HERBERTANDA 0871571984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% OINTMENT TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEPHARMAFAIRANDA 0884991984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEPHARMAFAIRANDA 0885061984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEPHARMAFAIRANDA 0885071984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% OINTMENT TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEPHARMAFAIRANDA 0884491984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEPAI HOLDINGS PHARMANDA 0883121984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Discontinued — - ALPHARMA US PHARMSANDA 0883601984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEALPHARMA US PHARMSANDA 0883611984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% CREAM TOPICAL Discontinued — - SAVAGE LABSANDA 0881741983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% CREAM TOPICAL Discontinued — - ALLERGAN HERBERTANDA 0871581983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Discontinued — - SAVAGE LABSANDA 0881731983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Discontinued — - SAVAGE LABSANDA 0881721983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% OINTMENT TOPICAL Discontinued — - SAVAGE LABSANDA 0881711983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEALLIEDANDA 0880471982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEFOUGERA PHARMS INCANDA 0881701982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% CREAM TOPICAL Rx AT - FLUOCINOLONE ACETONIDEFOUGERA PHARMS INCANDA 0881691982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Rx AT - FLUOCINOLONE ACETONIDEINVATECHANDA 0880451982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEFOUGERA PHARMS INCANDA 0881681982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% OINTMENT TOPICAL Rx AT - FLUOCINOLONE ACETONIDEPHARMADERMANDA 0880461982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% OINTMENT TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEALLIEDANDA 0880481982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEFOUGERA PHARMS INCANDA 0881671982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Rx AT - FLUOCINOLONE ACETONIDEALPHARMA US PHARMSANDA 0871591982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% SOLUTION TOPICAL Discontinued — - ALLERGAN HERBERTANDA 0873001982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% GEL TOPICAL Discontinued — - FLUOCINOLONE ACETONIDESUN PHARMA CANADAANDA 0871021982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDESUN PHARMA CANADAANDA 0871041982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEPERRIGO NEW YORKANDA 0868101982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.01% CREAM TOPICAL Discontinued — - FLUOCINOLONE ACETONIDEPERRIGO NEW YORKANDA 0868111982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.025% CREAM TOPICAL Discontinued —
Patent & exclusivity timeline
Protection horizon
Patent expiryExclusivity endToday
Listed patents
Orange Book patent file
| Patent | Expires | In | Type |
|---|---|---|---|
| 8871241 | in 10 mo | Product | |
| 7998108 | in 1 yr 3 mo | ProductU-3410 | |
| 9849027 | in 2 yr 1 mo | ProductU-708 |
Approval history
FDA approval span
First approval
45 yr 3 mo ago
Most recent approval
3 yr 3 mo ago
Approvals span 1982–2023 across 77 FDA applications.
Brand (NDA) 912%
Generic (ANDA) 6888%
Fluocinolone acetonide: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

